Patent Auctions: Biotech, Pharma Firms Start To Put Their IP On The Block
When the word got out last year that Cell Works was auctioning off its cancer diagnostic patents, IP Auctions, the outfit that held the online sale, was besieged with phone calls. More than a dozen drug companies, universities, research centers and venture capitalists wanted to know if the start-up biotech company was also putting its therapeutics patents on the auction block
You may also be interested in...
Company expects clinical trials to begin by September and says first batches could be available for emergency use authorization in early 2021; J&J pledges vaccine will be available to public on not-for-profit basis.
FTC and DoJ issue guidance for businesses working together to tackle coronavirus pandemic; BIO is 'pleased' they intend to help facilitate critical partnerships.
Teva and US FDA disagree over whether Copaxone is a protein. While generics are already on the market, Teva wants to assert process patents against future would-be competitors, which the firm cannot do through the ANDA pathway.